Mobile Integrated Health for Heart Failure
Trial Summary
What is the purpose of this trial?
This trial compares two methods of post-hospital care for heart failure patients: phone check-ins by a care coordinator and home visits by paramedics with video doctor consultations. The goal is to see which method better reduces hospital readmissions and improves patient quality of life.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but you should confirm with the trial coordinators.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the idea that Mobile Integrated Health for Heart Failure is an effective treatment?
The available research shows that Mobile Integrated Health can effectively reduce hospital readmissions for heart failure patients. For example, the MIGHTy-Heart study aims to compare the effectiveness of Mobile Integrated Health and telehealth in supporting patients after they leave the hospital. Additionally, a study on transition management services found that hospital readmission rates decreased from 17.9% to 8.0% after implementing these services, which are similar to Mobile Integrated Health. This suggests that Mobile Integrated Health can help keep heart failure patients healthier and out of the hospital.12345
What data supports the effectiveness of the treatment Mobile Integrated Health for Heart Failure?
Research shows that Mobile Integrated Health, which includes care coordination and transitional care, can improve patient outcomes by reducing hospital readmissions and enhancing communication during care transitions. For example, a study found that integrating transition management services in primary care reduced hospital readmission rates from 17.9% to 8.0%, demonstrating the potential effectiveness of such approaches in managing chronic conditions like heart failure.12345
What safety data exists for Mobile Integrated Health for Heart Failure?
The research indicates that Mobile Integrated Health (MIH) and related models like Community Paramedicine and Transitional Care aim to improve care coordination and reduce hospital readmissions for heart failure patients. These models focus on continuous management and communication across care settings, which can potentially reduce adverse events associated with poor care transitions. However, specific safety data for these interventions is not detailed in the provided research, suggesting a need for further studies to evaluate their safety comprehensively.678910
Is Mobile Integrated Health generally safe for humans?
The research on Mobile Integrated Health and similar programs like Community Paramedicine and Transitional Care suggests they focus on improving care coordination and reducing hospital readmissions, which implies they are generally safe for humans. These programs aim to enhance patient care without introducing new risks.678910
Is Mobile Integrated Health a promising treatment for heart failure?
Yes, Mobile Integrated Health is a promising treatment for heart failure. It can improve patient care, reduce hospital readmissions, and fill gaps in local healthcare by using emergency medical services in new ways. This approach helps patients manage their condition better at home, which can lead to fewer hospital visits and better overall health outcomes.29111213
How is the Mobile Integrated Health treatment for heart failure different from other treatments?
Mobile Integrated Health for heart failure is unique because it uses emergency medical services personnel to provide care at home, reducing the need for hospital visits. This approach focuses on improving care coordination and preventing hospital readmissions by offering personalized, in-home support and monitoring.29111213
Research Team
Leah Shafran Topaz, BPT, MSc
Principal Investigator
Weill Medical College of Cornell University
Ruth M. Masterson Creber, PhD, MSc, RN
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for Medicare or Medicaid recipients with heart failure in NYC (Manhattan, Brooklyn, Queens, Bronx) who are getting out of the hospital. It's not for those who don't speak English, Spanish, Mandarin, or French; have dementia/psychosis; will go to/receive care from a nursing facility/rehab/hospice; or await a heart transplant/LVAD.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Mobile Integrated Health or Transitions of Care Coordinator interventions after hospital discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mobile Integrated Health
- Transitions of Care Coordinator
Mobile Integrated Health is already approved in United States for the following indications:
- Congestive Heart Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Pneumonia
- Cellulitis
- Dehydration
- COVID-19
- Behavioral Health Conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Weill Medical College of Cornell University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator